Oakbrook Investments LLC Takes $289,000 Position in Walgreens Boots Alliance Inc (WBA)

Oakbrook Investments LLC purchased a new position in Walgreens Boots Alliance Inc (NASDAQ:WBA) in the 3rd quarter, HoldingsChannel reports. The institutional investor purchased 3,960 shares of the pharmacy operator’s stock, valued at approximately $289,000.

Several other institutional investors have also made changes to their positions in WBA. Massachusetts Financial Services Co. MA bought a new stake in shares of Walgreens Boots Alliance in the second quarter worth about $199,228,000. LSV Asset Management boosted its position in shares of Walgreens Boots Alliance by 17.2% during the second quarter. LSV Asset Management now owns 8,704,233 shares of the pharmacy operator’s stock worth $522,384,000 after buying an additional 1,277,546 shares during the period. Caisse DE Depot ET Placement DU Quebec boosted its position in shares of Walgreens Boots Alliance by 11.5% during the second quarter. Caisse DE Depot ET Placement DU Quebec now owns 11,110,617 shares of the pharmacy operator’s stock worth $666,804,000 after buying an additional 1,143,819 shares during the period. Burgundy Asset Management Ltd. boosted its position in shares of Walgreens Boots Alliance by 16.0% during the second quarter. Burgundy Asset Management Ltd. now owns 7,161,408 shares of the pharmacy operator’s stock worth $429,792,000 after buying an additional 986,275 shares during the period. Finally, Assenagon Asset Management S.A. boosted its position in shares of Walgreens Boots Alliance by 862.0% during the second quarter. Assenagon Asset Management S.A. now owns 1,040,549 shares of the pharmacy operator’s stock worth $62,449,000 after buying an additional 932,386 shares during the period. Institutional investors own 64.83% of the company’s stock.

In related news, Director William C. Foote sold 2,736 shares of the stock in a transaction that occurred on Thursday, August 2nd. The stock was sold at an average price of $65.99, for a total transaction of $180,548.64. Following the completion of the transaction, the director now directly owns 10,943 shares of the company’s stock, valued at $722,128.57. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 14.80% of the company’s stock.



Shares of NASDAQ WBA opened at $76.23 on Monday. Walgreens Boots Alliance Inc has a 52 week low of $59.07 and a 52 week high of $80.68. The company has a quick ratio of 0.38, a current ratio of 0.82 and a debt-to-equity ratio of 0.47. The company has a market cap of $72.35 billion, a P/E ratio of 12.66, a P/E/G ratio of 1.19 and a beta of 1.04.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings results on Thursday, October 11th. The pharmacy operator reported $1.48 EPS for the quarter, beating the consensus estimate of $1.45 by $0.03. Walgreens Boots Alliance had a return on equity of 21.75% and a net margin of 3.82%. The firm had revenue of $33.44 billion during the quarter, compared to analysts’ expectations of $33.64 billion. As a group, equities research analysts anticipate that Walgreens Boots Alliance Inc will post 6.53 EPS for the current year.

The business also recently declared a quarterly dividend, which will be paid on Wednesday, December 12th. Investors of record on Monday, November 12th will be given a dividend of $0.44 per share. The ex-dividend date is Thursday, November 8th. This represents a $1.76 annualized dividend and a yield of 2.31%. Walgreens Boots Alliance’s dividend payout ratio (DPR) is presently 29.24%.

Several research firms have recently weighed in on WBA. Barclays upped their price objective on Walgreens Boots Alliance from $77.00 to $80.00 and gave the stock an “equal weight” rating in a research report on Friday, October 12th. BidaskClub raised Walgreens Boots Alliance from a “hold” rating to a “buy” rating in a research report on Wednesday, September 12th. Citigroup upped their price objective on Walgreens Boots Alliance from $69.00 to $76.00 and gave the stock a “neutral” rating in a research report on Friday, October 12th. Zacks Investment Research raised Walgreens Boots Alliance from a “hold” rating to a “buy” rating and set a $81.00 price objective for the company in a research report on Tuesday, September 25th. Finally, Robert W. Baird upped their price objective on Walgreens Boots Alliance from $64.00 to $69.00 and gave the stock a “neutral” rating in a research report on Tuesday, September 11th. One equities research analyst has rated the stock with a sell rating, eleven have issued a hold rating, seven have issued a buy rating and two have given a strong buy rating to the stock. The company has an average rating of “Hold” and an average price target of $78.22.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of general merchandise, including non-prescription drugs, beauty products, photo finishing, seasonal merchandise, greeting cards, and convenience foods through its retail drugstores and convenient care clinics.

See Also: What Factors Can Affect Return on Equity?

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply